• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Mergers and Acquisitions in the IVD Market

$2,000.00 – $4,000.00

Clear
SKU: 19-043 Category: Diagnostics Market Research Tags: acquisitions in vitro diagnostics market, acquisitions IVD, in vitro diagnostics market mergers and acquisitions, M&A in vitro diagnostics, M&A IVD, mergers and acquisitions IVD, mergers in vitro diagnostics market, mergers IVD Pages: 103
  • Description
  • Table of Contents
  • Latest reports

Description

In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. In this environment, companies are making strategic acquisitions that simultaneously add a revenue stream and product innovation. Kalorama Information looks at these market transactions in Mergers and Acquisitions in the IVD Market, recording more than 220 acquisitions in the diagnostics industry from 2016 to June 2019.

Though some segments of the overall IVD market are still relatively small, they represent the biggest growth areas in the market. The report focuses on acquisitions in these growing segments of great market interest, anticipated to be a big part of the future of IVD, including the following:

  • Next-Generation Sequencing (NGS)
  • Cancer Testing (Liquid Biopsy)
  • Companion Diagnostics

The merger and acquisition activities of major players in the market are of course of interest as well, therefore the report provides detailed discussion of activities of leading companies, including:

  • Roche
  • Abbott
  • Danaher

Detailed listings of company buys are featured in the report:

  • Selected Acquisitions of Diagnostic Companies, from 2018 to end June 2019
  • Selected Acquisitions of Diagnostic Companies, 2016-2017

From 2018 to 2019, the report provides summaries of the market impact of numerous transactions, including:

  • Danaher / Beckman Coulter Acquisitions in 2018 / 2019
  • QIAGEN M&A Activity
  • bioMérieux Activity in M&A
  • Illumina Acquisitions of PacBio, Edico Genome

From 2016 to 2017, the report provides summaries of the market impact of numerous transactions, including:

  • Abbott’s Acquisitions, Divestures and the Alere Deal
  • Siemens’ M&A Activity in Recent Years
  • Konica Minolta’s Acquisitions of Ambry Genetics and Invicro, Building a Presence in Precision Medicine
  • Thermo’s Completion of the Patheon Acquisition
  • Danaher’s Acquisition of Molecular Diagnostics Leader Cepheid for Nearly $4 Billion

The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.

Table of Contents

1: Executive Summary
The Market Landscape

  • Overview
  • Next-Generation Sequencing
  • Cancer Testing (Liquid Biopsy)
  • Companion Diagnostics
  • The Clinical Laboratory Services Market

Mergers and Acquisitions of Some Major Market Players

  • Roche
  • Abbottís Molecular Diagnostics Business Post-Acquisition of Alere
  • Danaher
  • Siemens
  • Thermo Fisher Scientific

Mergers and Acquisitions across Various Market Segments

  • NGS Market Landscape Changing Fast
  • Cancer Testing (Liquid Biopsy)
  • Companion Diagnostics
  • Immunohistochemistry (Immunoassay) Market
  • Lab-Developed Test (LDT) Services Market
  • The PCR/NAAT Market
  • The Molecular Transplant Diagnostics Segment

Methodology

2: IVD Mergers and Acquisitions
Brief Overview: The IVD Industry

    • Table 2-1: Selected Acquisitions of Diagnostic Companies, from 2018 to end June 2019

Selected 2018 / 2019 Acquisitions of Note

  • Danaher / Beckman Coulter Acquisitions in 2018 / 2019
  • Meridian Enters Syndromic with GenePOC Acquisition
  • Thermo Fisher Acquires Provider of Mass Spectrometry Software
  • QIAGEN M&A Activity
  • PerkinElmer Acquires Cell Assay Company
  • Charles River Labsí M&A Activity
  • bioMÈrieux Active in M&A
  • Eli Lilly acquires Loxo Oncology for $8 billion
  • Luminex Completes Acquisition of MilliporeSigma’s Flow Cytometry Product Line
  • OraSure Acquires CoreBiome and Novosanis
  • Illumina Acquires PacBio, Edico Genome
  • Agilent Active in M&A
  • Recent Acquisitions by Quest
  • Precision for Medicine Acquires ApoCell
  • Bruker Acquires Majority Interest in Hain Lifescience, Infectious Disease-focused MDx Company
  • Grifols Expands Its Plasma Collection Network
  • Tecan Acquires NGS Company
  • Myriad Genetics Acquires Counsyl
  • Vela Diagnostics Buys Great Basin Scientific
  • Celgene Active in Early 2018
  • Early 2018 M&A Activity in Biotech — Sanofi Buys Bioverativ, Ablynx

Selected 2016 / 2017 Acquisitions of Note

    • Table 2-2: Selected Acquisitions of Diagnostic Companies, 2016-2017
  • Chembio Diagnostics Acquires Malaysian Firm RVR Diagnostics
  • Abbott: Acquisitions, Divestures and the Alere Deal
  • Konica Minolta Acquires Ambry Genetics and Invicro, Building a Presence in Precision Medicine
  • Siemensí Activity in Recent Years
  • Quidel Amends Alere Deal
  • Thermo Completes Patheon Acquisition
  • Agilent Acquires the Molecular and Sample Barcoding Patent Portfolios of Population Genetics
  • Enterome and Nestle Health Science Form Microbiome Diagnostics Partners
  • PerkinElmer Expansion via Tulip and Euroimmun Acquisitions
  • Sysmex Acquires Oxford Gene Technology (OGT)
  • LabCorp Completes PAML Acquisition
  • Cathay Fortune International Acquires Molecular Diagnostics Firm Epigenomics
  • Hologic Acquires Cynosure
  • Bio-Rad Acquires ddPCR Developer RainDance
  • Grifols Acquires NAT Donor Screening Unit from Hologic
  • Johnson & Johnson Diabetes Business Attracts Chinese Interest
  • Danaher Acquires Molecular Diagnostics Leader Cepheid for Nearly $4 Billion
  • Abbott Acquires St. Jude Medical, Adds Patient Monitoring and Neurostimulation Strength
  • Founding CTC Technology Finds Another Home
  • Curetis Acquisitions: Real-Time qPCR-based Gyronimo Platform and Asset from Siemens Technology Accelerator
  • Bruker Acquires Nucleic Acid Testing Assays and Syndromic Panel Technology
  • LabCorp Completes Its Acquisition of Sequenom
  • Bio-Techne Acquires Advanced Cell Diagnostics (ACD)
  • Debiopharm Group Acquires GenePOC
  • Luminex Acquires Nanosphereís Verigene Platform
  • Quest and DiaSorin Focused on Key Markets Following 2016 Acquisition Deal
  • Immucor Acquires Sirona Genomics
  • Illumina Establishes GRAIL Bio
  • Charles River Acquires Agilux and WIL Research
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    The U.S. Market for Interventional Radiology Products

    $3,500.00 – $7,000.00
  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    $4,995.00 – $9,990.00
  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The World Molecular Diagnostics Market, 8th EditionUnderstanding the Clinical Diagnostics Customer Experience: Results of the 2019...
Scroll to top